Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples

BACKGROUND: Bladder cancer (BC) is the 5th most common cancer in the USA. Non-muscle invasive bladder cancer represents about 70% of all cases and has generally a favorable outcome. However, recurrence rates as high as 60 to 70% and progression rates of 10 to 20% necessitate intensive surveillance w...

Descripción completa

Detalles Bibliográficos
Autores principales: Piatti, Paolo, Chew, Yap Ching, Suwoto, Michiko, Yamada, Taikun, Jara, Benjamin, Jia, Xi-Yu, Guo, Wei, Ghodoussipour, Saum, Daneshmand, Siamak, Ahmadi, Hamed, Rice, Jeffrey, Bhasin, Jeffrey, Holloway, Faith, Tsai, Yvonne, Chihara, Yoshitomo, Liang, Gangning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059345/
https://www.ncbi.nlm.nih.gov/pubmed/33882992
http://dx.doi.org/10.1186/s13148-021-01029-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059345/
https://www.ncbi.nlm.nih.gov/pubmed/33882992
http://dx.doi.org/10.1186/s13148-021-01029-1

Ejemplares similares